Drug therapy for the management of cancer related fatigue (Q24242050)

object named as

Michael Sharpe

0 references

Alison Richardson

object named as

Alison Richardson

0 references

author name string

Ollie Minton

0 references

Patrick Stone

Cochrane Database of Systematic Reviews

0 references

publication date

23 January 2008

0 references

published in

0 references

cites work

Randomized clinical trial of adenosine 5'-triphosphate in patients with advanced non-small-cell lung cancer.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006704.PUB2

Prevention of anemia in patients with solid tumors receiving platinum-based chemotherapy by recombinant human Erythropoietin (rHuEpo): a prospective, open label, randomized trial by the Hellenic Cooperative Oncology Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006704.PUB2

Impact of epoetin beta on quality of life in patients with malignant disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006704.PUB2

A controlled trial of megestrol acetate on appetite, caloric intake, nutritional status, and other symptoms in patients with advanced cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006704.PUB2

Effect of fish oil on appetite and other symptoms in patients with advanced cancer and anorexia/cachexia: a double-blind, placebo-controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006704.PUB2

Neurobehavioral effects of interferon-alpha in cancer patients: phenomenology and paroxetine responsiveness of symptom dimensions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006704.PUB2

Weekly epoetin alfa maintains hemoglobin, improves quality of life, and reduces transfusion in breast cancer patients receiving chemotherapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006704.PUB2

Improved quality of life after long-term treatment with the bisphosphonate ibandronate in patients with metastatic bone disease due to breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006704.PUB2

A double blind placebo controlled trial of medroxyprogesterone acetate (MPA) in cancer cachexia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006704.PUB2

Fluoxetine Versus Placebo in Advanced Cancer Outpatients: A Double-Blinded Trial of the Hoosier Oncology Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006704.PUB2

Recombinant human erythropoietin, epoetin beta, in patients with relapsed lymphoma treated with aggressive sequential salvage chemotherapy--results of a randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006704.PUB2

Efficacy and safety of darbepoetin alfa in anaemic patients with lymphoproliferative malignancies: a randomized, double-blind, placebo-controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006704.PUB2

Effect of recombinant human erythropoietin on quality of life in cancer patients receiving chemotherapy: results of a randomized, controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006704.PUB2

Randomized study of dexamethasone treatment for delayed emesis, anorexia and fatigue induced by irinotecan

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006704.PUB2

Maintaining normal hemoglobin levels with epoetin alfa in mainly nonanemic patients with metastatic breast cancer receiving first-line chemotherapy: a survival study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006704.PUB2

Effects of epoetin alfa on hematologic parameters and quality of life in cancer patients receiving nonplatinum chemotherapy: results of a randomized, double-blind, placebo-controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006704.PUB2

Differential effects of paroxetine on fatigue and depression: a randomized, double-blind trial from the University of Rochester Cancer Center Community Clinical Oncology Program

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006704.PUB2

Feasibility of quantifying the effects of epoetin alfa therapy on cognitive function in women with breast cancer undergoing adjuvant or neoadjuvant chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006704.PUB2

Randomized, double-blind, placebo-controlled trial of recombinant human erythropoietin, epoetin Beta, in hematologic malignancies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006704.PUB2

Methylprednisolone as palliative therapy for female terminal cancer patients. The Methylprednisolone Female Preterminal Cancer Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006704.PUB2

Effect of paroxetine hydrochloride (Paxil) on fatigue and depression in breast cancer patients receiving chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006704.PUB2

Effects of early intervention with epoetin alfa on transfusion requirement, hemoglobin level and survival during platinum-based chemotherapy: Results of a multicenter randomised controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006704.PUB2

Effects of medroxyprogesterone acetate on appetite, weight, and quality of life in advanced-stage non-hormone-sensitive cancer: a placebo-controlled multicenter study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006704.PUB2

A dose- and schedule-finding study of darbepoetin alpha for the treatment of chronic anaemia of cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006704.PUB2

Epoetin alpha prevents anaemia and reduces transfusion requirements in patients undergoing primarily platinum-based chemotherapy for small cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006704.PUB2

Double-blind, placebo-controlled, randomized phase III trial of darbepoetin alfa in lung cancer patients receiving chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006704.PUB2

Megestrol acetate in advanced, progressive, hormone-insensitive cancer. Effects on the quality of life: a placebo-controlled, randomised, multicentre trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006704.PUB2

Epoetin alfa in platinum-treated ovarian cancer patients: results of a multinational, multicentre, randomised trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006704.PUB2

Phase III, randomized, double-blind study of epoetin alfa compared with placebo in anemic patients receiving chemotherapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006704.PUB2

Randomized, double-blind, placebo-controlled trial of erythropoietin in non-small-cell lung cancer with disease-related anemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006704.PUB2

A randomized, active-control, pilot trial of front-loaded dosing regimens of darbepoetin-alfa for the treatment of patients with anemia during chemotherapy for malignant disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006704.PUB2

Randomized comparison of every-2-week darbepoetin alfa and weekly epoetin alfa for the treatment of chemotherapy-induced anemia: the 20030125 Study Group Trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006704.PUB2

Epoetin beta in the treatment of anemia in patients with advanced gastrointestinal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006704.PUB2

Efficacy of epoetin beta on hemoglobin, quality of life, and transfusion needs in patients with anemia due to hormone-refractory prostate cancer--a randomized study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006704.PUB2

Neuropsychiatric syndromes and psychological symptoms in patients with advanced cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006704.PUB2

A randomized, double-blind, placebo-controlled trial of psychostimulants for the treatment of fatigue in ambulatory patients with human immunodeficiency virus disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006704.PUB2

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006704.PUB2

Exercise for treatment of cancer related fatigue

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006704.PUB2

Quality-of-life benefit in chemotherapy patients treated with epoetin alfa is independent of disease response or tumor type: results from a prospective community oncology study. Procrit Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006704.PUB2

Impact of therapy with epoetin alfa on clinical outcomes in patients with nonmyeloid malignancies during cancer chemotherapy in community oncology practice. Procrit Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006704.PUB2

Assessing the quality of reports of randomized clinical trials: is blinding necessary?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006704.PUB2

Epoetin alfa improves quality of life in patients with cancer: results of metaanalysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006704.PUB2

A population-based incidence study of chronic fatigue.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006704.PUB2

Evidence-based treatment for cancer-related fatigue

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006704.PUB2

Fatigue associated with cancer and its treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006704.PUB2

Management of cancer-related fatigue

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006704.PUB2

Drugs for the treatment of fatigue in palliative care

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006704.PUB2

Preliminary evaluation of a clinical syndrome approach to assessing cancer-related fatigue.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006704.PUB2

Fatigue after breast cancer and in chronic fatigue syndrome: similarities and differences

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006704.PUB2

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006704.PUB2

The measurement, causes and effective management of cancer-related fatigue

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006704.PUB2

Fatigue in Multiple Sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006704.PUB2

7 January 2021

Corticosteroid therapy of preterminal gastrointestinal cancer

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006704.PUB2

7 January 2021

Effect of methylprednisolone sodium succinate on quality of life in preterminal cancer patients: a placebo-controlled, multicenter study. The Methylprednisolone Preterminal Cancer Study Group

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006704.PUB2

7 January 2021

Fatigue and psychological distress in the working population

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006704.PUB2

7 January 2021

Combining anchor and distribution-based methods to derive minimal clinically important differences on the Functional Assessment of Cancer Therapy (FACT) anemia and fatigue scales

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006704.PUB2

7 January 2021

Darbepoetin alfa administered every 3 weeks alleviates anaemia in patients with solid tumours receiving chemotherapy; results of a double-blind, placebo-controlled, randomised study

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006704.PUB2

7 January 2021

Megestrol acetate for anorexia in patients with far-advanced cancer: a double-blind controlled clinical trial

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006704.PUB2

7 January 2021

Efficacy of epoetin alfa in the treatment of anaemia of multiple myeloma

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006704.PUB2

7 January 2021

Recombinant human erythropoietin therapy for anemic cancer patients on combination chemotherapy

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006704.PUB2

7 January 2021

Phase III study of two different dosing schedules of erythropoietin in anemic patients with cancer

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006704.PUB2

7 January 2021

Patient-controlled methylphenidate for cancer fatigue: a double-blind, randomized, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006704.PUB2

7 January 2021

Assessment of tumor necrosis factor alpha blockade as an intervention to improve tolerability of dose-intensive chemotherapy in cancer patients

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006704.PUB2

7 January 2021

Randomized comparison of epoetin alfa (40,000 U weekly) and darbepoetin alfa (200 microg every 2 weeks) in anemic patients with cancer receiving chemotherapy

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006704.PUB2

7 January 2021

10.1002/14651858.CD006704.PUB2

Identifiers

DOI

1 reference

Consolidated OpenCitations Corpus – April 2017

OpenCitations bibliographic resource ID

4307728

OpenCitations bibliographic resource ID

4307728

1 reference